Home

Jeffrey Humphrey

CIK 1816944 · Chief Medical Officer · last filed 2024-06-20

Jeffrey Humphrey is a Chief Medical Officer who has filed 11 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing shows the insider was granted $749.9K of LNTH on Jun 20, 2024. Current disclosed insider exposure totals $948.6K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$948.6K

Companies

4

Total Filings

11

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LNTH Chief Medical Officer 9,076 $104.52 $948.6K $0 1 2024-06-20
Cyteir Therapeutics, Inc. (CYT) Delisted Director — $3.02 — $0 3 2023-02-07
Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Chief Medical Officer — $11.19 — $0 4 2022-08-01
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Chief Medical Officer — $33.99 — $0 2 2021-02-18

Recent Filings

11 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-20 LNTH Grant (A) +9,076 $749.9K EDGAR
2023-02-07 Cyteir Therapeutics, Inc. (CYT) Delisted Grant (A) — $0 EDGAR
2022-08-01 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) — $0 EDGAR
2022-05-19 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) — $0 EDGAR
2022-02-24 Cyteir Therapeutics, Inc. (CYT) Delisted Grant (A) — $0 EDGAR
2022-02-17 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) — $0 EDGAR
2021-12-16 Cyteir Therapeutics, Inc. (CYT) Delisted Grant (A) — $0 EDGAR
2021-10-04 Dianthus Therapeutics, Inc. /DE/ (MGTA) Delisted Grant (A) — $0 EDGAR
2021-07-19 — Disp (D) — $0
2021-02-18 CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.